Share Email Print

Journal of Biomedical Optics

Advances in contrast agents, reporters, and detection
Author(s): Darryl J. Bornhop; Christopher H. Contag; Kai Licha; Catherine J. Murphy
Format Member Price Non-Member Price
PDF $20.00 $25.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

The use of exogenous probes to gain a deeper understanding of physiological and molecular processes in vivo through the acquisition of optical signals, particularly via enhanced contrast using molecular probes ~physiologically transported, site-directed, or via reporter genes! has emerged with tremendous vigor in the past few years. One such area of expanded activity is in the area of early cancer detection, in great part because it is so critical to the clinical outcome in the treatment.1–3 As an example, in colon cancer, which accounts for 15% of all U.S. cancer-related deaths, only 37% are found early enough for moderate treatment1 and once these types of cancer reach metastatic activity the survival rate is only 7%.

Paper Details

Date Published: 1 April 2001
J. Biomed. Opt. 6(2) doi: 10.1117/1.1360394
Published in: Journal of Biomedical Optics Volume 6, Issue 2
Show Author Affiliations
Darryl J. Bornhop, Texas Tech Univ. (United States)
Christopher H. Contag, Stanford Univ. School of Medicine (United States)
Kai Licha, Freie Univ. Berlin (Germany)
Catherine J. Murphy, Univ. of South Carolina (United States)

© SPIE. Terms of Use
Back to Top